Study Finds That Dialysis Patients Who Use DaVita Rx Live Longer
Improved Mortality and Fewer Hospital Stays for Dialysis Patients Using DaVita
DALLAS -- April 24, 2013
DaVita®, a division of DaVita HealthCare Partners Inc. (NYSE: DVA) and a
leading provider of kidney care services, today announced study results
showing that, on average, patients using its pharmacy, DaVita Rx®, are 21
percent more likely to live longer than patients who do not use DaVita Rx.
The study, recently published by the American Journal of Kidney Diseases, also
found that dialysis patients who use DaVita Rx spent 14 percent fewer days in
the hospital each year, which equates to 1.8 fewer hospital days per patient
per year. The independent study was conducted by the Chronic Disease Research
Group (CDRG), who analyzed the hospitalizations and mortality of more than
50,000 DaVita patients.
“We created DaVita Rx in 2005 because we knew it would make a difference in
the lives of our patients,” said Kent Thiry, co-chairman and CEO of DaVita
HealthCare Partners. “We have critically ill patients who often take more than
20 pills per day, prescribed by multiple physicians, in addition to hours of
dialysis treatments. This study confirms our belief that a pharmacy program
can improve mortality, clinical outcomes and quality of life.”
The CDRG obtained data for this study through the United States Renal Data
System. The study’s control group was made of 43,013 DaVita patients using
other pharmacies to receive their medications. The study group of 8,864 DaVita
patients used the DaVita Rx pharmacy service over the 2.5 years between 2006
DaVita Rx is the world’s first and largest full-service pharmacy specializing
in kidney care, serving a growing percentage of dialysis patients at DaVita
and other dialysis providers. Suffering from end stage renal disease and often
other chronic illnesses, these patients receive medications while dialyzing at
their local dialysis center or at home. Patients also benefit from services
including 24-hour access to specially-trained pharmacists, flexible payment
options, refill reminders and insurance assistance.
For more information on DaVita, please visit www.DaVita.com. To learn more
about DaVita Rx and this study, please visit www.DaVitaRx.com.
DaVita, DaVita Rx and DaVita HealthCare Partners are trademarks or registered
trademarks of DaVita HealthCare Partners Inc. All other marks are the property
of their respective owners.
DaVita is the dialysis division of DaVita HealthCare Partners Inc., a Fortune
500® company that, through its operating divisions, provides a variety of
health care services to patient populations throughout the United States and
abroad. A leading provider of kidney care in the United States, DaVita
delivers dialysis services to patients with chronic kidney failure and end
stage renal disease. DaVita strives to improve patients’ quality of life by
innovating clinical care, and by offering integrated treatment plans,
personalized care teams and convenient health-management services. As of Dec.
31, 2012, DaVita operated or provided administrative services at 1,954
outpatient dialysis centers located in the United States serving approximately
153,000 patients. The company also operated 36 outpatient dialysis centers
located in eight countries outside the United States. DaVita supports numerous
programs dedicated to creating positive, sustainable change in communities
around the world. The company’s leadership development initiatives and social
responsibility efforts have been recognized by Fortune, Modern Healthcare,
Newsweek and WorldBlu. For more information, please visit DaVita.com.
About DaVita Rx
DaVita Rx is the first and largest full-service pharmacy created specifically
for the unique needs of kidney patients. DaVita Rx makes it easier for
patients to get their medications and follow their drug regimens with services
such as 24-hour access to specially trained pharmacists, refill reminders,
flexible payment options, and no-cost delivery. DaVita Rx also helps patients
and providers navigate the changing health care laws and rules. For more
information, please visit www.davitarx.com/.
Bianca Violante, 303-876-6614
Press spacebar to pause and continue. Press esc to stop.